34.80
price up icon5.58%   1.84
after-market Dopo l'orario di chiusura: 34.79 -0.010 -0.03%
loading

Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
67.14%
164.74
98.56 74.57 55.47 46.24
Operating Income/Loss
67.14%
-164.74
-98.56 -74.57 -55.47 -46.24
Income/Loss From Continuing Operations Before Tax
73.66%
-157.66
-90.79 -65.56 -45.63 -35.42
Income/Loss From Continuing Operations After Tax
73.66%
-157.66
-90.79 -65.56 -45.63 -35.42
Net Income/Loss
73.66%
-157.66
-90.79 -65.56 -45.63 -35.42
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.60%
0.45
112.32 112.13 112.07 0.775
Diluted Average Shares
99.60%
0.45
112.32 112.13 112.07 0.775
Basic Earnings Per Share
71.60%
-1.39
-0.81 -0.58 -0.41 -0.32
Diluted Earnings Per Share
71.60%
-1.39
-0.81 -0.58 -0.41 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):